These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 25322897)

  • 21. Reliability of blood pressure parameters for dry weight estimation in hemodialysis patients.
    Susantitaphong P; Laowaloet S; Tiranathanagul K; Chulakadabba A; Katavetin P; Praditpornsilpa K; Tungsanga K; Eiam-Ong S
    Ther Apher Dial; 2013 Feb; 17(1):9-15. PubMed ID: 23379487
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [N-terminal pro brain natriuretic peptide predicts hospitalization of hemodialysis patients for cardiovascular disease].
    Naito T; Masaki T; Shimizu Y; Ogawa T; Ochiai M; Hamaguchi N; Hirashio S; Doi T; Yokoyama Y; Yorioka N
    Nihon Jinzo Gakkai Shi; 2011; 53(4):633-41. PubMed ID: 21688486
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of body composition using dry mass index and ratio of total body water to estimated volume based on bioelectrical impedance analysis in chronic kidney disease patients.
    Ohashi Y; Otani T; Tai R; Tanaka Y; Sakai K; Aikawa A
    J Ren Nutr; 2013 Jan; 23(1):28-36. PubMed ID: 22406124
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantifying acute changes in volume and nutritional status during haemodialysis using bioimpedance analysis.
    Chua HR; Xiang L; Chow PY; Xu H; Shen L; Lee E; Teo BW
    Nephrology (Carlton); 2012 Nov; 17(8):695-702. PubMed ID: 22882488
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nutritional status and overhydration: can bioimpedance spectroscopy be useful in haemodialysis patients?
    Garagarza C; João-Matias P; Sousa-Guerreiro C; Amaral T; Aires I; Ferreira C; Jorge C; Gil C; Ferreira A
    Nefrologia; 2013; 33(5):667-74. PubMed ID: 24089158
    [TBL] [Abstract][Full Text] [Related]  

  • 26. N-Terminal Prohormone of Brain Natriuretic Peptide but not C-Terminal Pre-Pro Vasopressin (Copeptin) Level is Associated with the Response to Antihypertensive Therapy in Haemodialysis Patients.
    Wyskida K; Ficek J; Ficek R; Adamska D; Jędrzejowska P; Wajda J; Klein D; Witkowicz J; Rotkegel S; Spiechowicz-Zatoń U; Kocemba-Dyczek J; Ciepał J; Więcek A; Olszanecka-Glinianowicz M; Chudek J
    Kidney Blood Press Res; 2017; 42(6):1013-1022. PubMed ID: 29190613
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of bioelectrical impedance analysis, NT-ProBNP and inferior vena cava sonography in the assessment of body fluid volume in children with nephrotic syndrome.
    Nalcacioglu H; Ozkaya O; Baysal K; Kafali HC; Avci B; Tekcan D; Genc G
    Nefrologia (Engl Ed); 2018; 38(1):48-56. PubMed ID: 28751054
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Importance of volume factors in dialysis related hypertension.
    Lins RL; Elseviers M; Rogiers P; Van Hoeyweghen RJ; De Raedt H; Zachee P; Daelemans RA
    Clin Nephrol; 1997 Jul; 48(1):29-33. PubMed ID: 9247775
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reference values for multifrequency bioimpedance analysis in dialysis patients.
    van de Kerkhof J; Hermans M; Beerenhout C; Konings C; van der Sande FM; Kooman JP
    Blood Purif; 2004; 22(3):301-6. PubMed ID: 15256796
    [TBL] [Abstract][Full Text] [Related]  

  • 30. N-terminal probrain natriuretic peptide as a predictor of short-term outcomes in acute myocardial infarction.
    Puri A; Narain VS; Mehrotra S; Dwivedi SK; Saran RK; Puri VK
    Indian Heart J; 2005; 57(4):304-10. PubMed ID: 16350675
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of overhydration, Kt/Vurea, β2-microglobulin on coronary artery calcification and mortality in haemodialysis patients.
    Mizuiri S; Nishizawa Y; Yamashita K; Doi T; Okubo A; Morii K; Usui K; Arita M; Naito T; Shigemoto K; Masaki T
    Nephrology (Carlton); 2024 Jul; 29(7):422-428. PubMed ID: 38515301
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Usefulness of combined high-sensitive C-reactive protein and N-terminal-probrain natriuretic peptide for predicting cardiovascular events in patients with suspected coronary artery disease.
    Huang PH; Lu TM; Wu TC; Lin FY; Chen YH; Chen JW; Lin SJ
    Coron Artery Dis; 2008 May; 19(3):187-93. PubMed ID: 18418236
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiac biomarkers and survival in haemodialysis patients.
    Sommerer C; Beimler J; Schwenger V; Heckele N; Katus HA; Giannitsis E; Zeier M
    Eur J Clin Invest; 2007 May; 37(5):350-6. PubMed ID: 17461980
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association between OH/ECW and echocardiographic parameters in CKD5 patients not undergoing dialysis.
    Han BG; Song SH; Yoo JS; Park H; Kim J; Choi E
    PLoS One; 2018; 13(4):e0195202. PubMed ID: 29630661
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of B-type natriuretic peptides for assessment of cardiac function and prognosis in stable ischemic heart disease.
    Richards M; Nicholls MG; Espiner EA; Lainchbury JG; Troughton RW; Elliott J; Frampton CM; Crozier IG; Yandle TG; Doughty R; MacMahon S; Sharpe N; ;
    J Am Coll Cardiol; 2006 Jan; 47(1):52-60. PubMed ID: 16386664
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship between extracellular water fraction of total body water estimated by bioimpedance spectroscopy and cardiac troponin T in chronic haemodialysis patients.
    Park J; Chung HC; Kim MS; Kim SJ; Chang JW; Lee JS
    Blood Purif; 2009; 28(1):61-8. PubMed ID: 19346743
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Extracellular overhydration linked with endothelial dysfunction in the context of inflammation in haemodialysis dependent chronic kidney disease.
    Mitsides N; Cornelis T; Broers NJH; Diederen NMP; Brenchley P; van der Sande FM; Schalkwijk CG; Kooman JP; Mitra S
    PLoS One; 2017; 12(8):e0183281. PubMed ID: 28829810
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of N-terminal pro-brain natriuretic peptide digit number for screening of cardiac disease in new haemodialysis patients.
    Iwasaki M; Joki N; Tanaka Y; Ikeda N; Hayashi T; Kubo S; Asakawa T; Takahashi Y; Hirahata K; Imamura Y; Hase H
    Nephrology (Carlton); 2013 Jul; 18(7):497-504. PubMed ID: 23574011
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum CA125 a potential marker of volume status for peritoneal dialysis patients?
    Wijayaratne D; Muthuppalaniappan VM; Davenport A
    Int J Artif Organs; 2021 Dec; 44(12):1029-1033. PubMed ID: 34041949
    [TBL] [Abstract][Full Text] [Related]  

  • 40. N-terminal pro-B-type natriuretic peptide in risk stratification after acute myocardial infarction in patients on long-term beta-adrenergic receptor blocker therapy.
    Jonsson G; Abdelnoor M; Landaas S; Muller C; Kjeldsen SE; Os I; Westheim A
    Cardiology; 2006; 106(2):102-8. PubMed ID: 16636540
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.